Lupus News Today

This is a short description about myself and what this site is about. I hope you enjoy being here!

Skip to content
  • Home
  • Categories
    • Lupus Foundation of America
    • Lupus Nephritis
    • Lupus Research Institute
    • SLE
  • About Lupus
    • Lupus Causes
    • Lupus Symptoms
    • Lupus Diagnosis
    • Living With Lupus
  • Lupus Treatment
    • Clinical Trial
      • Clinical Trials 101
  • Social Clips
  • FAQs
  • Columns
    • Diaries of a Lupus Chick
    • Hurricane in Heels
    • Keep It Moving
    • Learning to Live with Lupus
    • Lessons From A Chronic Life
    • Sick Girl Problems
    • The Girl Who Cried Wolf
  • Information About COVID-19

TREML4 As A New Regulator of Autoimmunity in Systemic Lupus Erythematosus

April 7, 2015April 7, 2015
Patricia Inacio, PhDby Patricia Inacio, PhD

In News.

TREML4 As A New Regulator of Autoimmunity in Systemic Lupus Erythematosus

Click here to subscribe to the Lupus News Today Newsletter.

0
(0)

shutterstock_158373833In a new study entitled “The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity,” researchers identified a new molecule – TREML4 – that promotes TLR7-mediated release of inflammatory cytokines in systemic lupus erythematosus. The study was published in the journal Nature Immunology.

Systemic lupus erythematosus or Lupus is an autoimmune disease caused by a hyperactive immune system that attacks normal, healthy tissue, and is characterized by inflammation of joints and organs, including heart, lungs, kidneys and brain.

Toll-like receptors (TLRs) are a family of receptors crucial for pathogen recognition resulting in activation of intracellular signaling pathways that culminate in the release of inflammatory molecules, such as cytokines crucial for host defense. However, TLR hyperactivation contributes to the development of chronic inflammatory and autoimmune diseases. A member of the TLR family, TLR7, has been linked to lupus in both mice and humans. Thus, TLR signaling, and in particular TLR7, has to be under a tight regulation to prevent the rise of autoimmunity.

Here, a group of researchers from the Massachusetts General Hospital (MGH) investigated which molecules regulate TLR7-induced activation of immune cells, focusing mainly on macrophages. To this end, the research team performed RNA-interference screenings in mice macrophages, “knocking-down” the expression of 8,000 genes. They identified a new molecule, TREML4, as a positive regulator of TLR7 signaling, i.e., immune cells lacking TREML4 were unable to respond properly to TLR7 signaling. The team performed further studies and observed that deleting TREML4 in a mouse model that develops TLR7-dependent lupus reduced autoimmunity, revealed by an improved inflammatory cytokine production and also kidney disease.

The authors stressed their results show TREML4 is a key regulator of TLR7 signaling and its expression is required for TLR7-mediated autoimmune diseases. Future research will address the potential role of inhibiting TREML4-mediated TLR7 signaling as a new treatment for lupus. However, since in the present study the results also showed that mice lacking TREML4 are more susceptible to influenza virus infection, researchers need to further understand TREML4’s role in antiviral host defense and determine if its role in autoimmunity can be inhibited without affecting it.

Terry Means, PhD, of the Center for Immunology and Inflammatory Diseases in the MGH Division of Rheumatology, Allergy, and Immunology and study lead author noted in a press release, “This study is the first demonstration that the receptor TREML4 amplifies the cellular responses transmitted through the TLR7 receptor and that a lack of such amplification prevents the inflammatory overactivation underlying lupus. Our preliminary results suggest that TREML4-regulated signaling through TLR7 may be a potential drug target to limit inflammation and the development of autoimmunity.”

  • Author Details
Patricia Inacio, PhD
Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.
×
Patricia Inacio, PhD
Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.
Latest Posts
  • voclosporin trial results
  • CLE disease measures
  • eye
  • galectin-9
Print This Page

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Click Here to receive Lupus News via e-mail

Tagged Systemic Lupus Erythematosus, TLR7, Toll-like receptors (TLRs), TREML4.

Post navigation

Previous: Researchers Report Two Predictors of Neuropsychological Dysfunction in Lupus Patients
Next:Novel Signaling Pathway Found to Act As Regulator Of Chronic Cutaneous Lupus Erythematosus

 

Recent Posts

  • goodbye, Rare Disease Day, fatigue, control, happiness, love, Extraordinary doctors

    Ending an Era: Saying Goodbye to ‘The Girl Who Cried Wolf’

    February 26, 2021

  • farewell, loss, 2020, positivity, perspective, self-esteem, judgmental thoughts, religious, compromise

    To My Lupus Community: I’m So Glad We Had This Time Together

    February 26, 2021

  • goodbye, Rare Disease Day, fatigue, control, happiness, love, Extraordinary doctors

    We May Be Rare, but We Are Not Alone on Rare Disease Day

    February 19, 2021

You May Also Like

Pain and Paranoia Are Part of the Lupus Life

January 20, 2020

mantra, plans, opinions, help, connection, social distancing, burden

Lupus Lessons: What Currencies Run Your Life?

January 17, 2020

body, body parts

Have I Given Up? The Search for Joy in My Battle

January 13, 2020

mantra, plans, opinions, help, connection, social distancing, burden
Visit Lupus News Today's profile on Pinterest.

Lupus News Today

BioNews Services, LLC
3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363
  • About Us
  • Our Team
  • Our Guiding Ethics
  • Contact Us
  • Terms of Service
  • Privacy Policy
  • Disable Notifications

Disclaimer:

Lupus News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Copyright © 2013-2022 All rights reserved.